Methods for cancer and immunotherapy using prodrugs of glutamine analogs Grant US-11759444-B2 United States of America 19 Sep 2023
Glutamine antagonists for the treatment of cognitive deficits and psychiatric disorders Grant US-11110104-B2 United States of America 07 Sep 2021
Methods for cancer and immunotherapy using prodrugs of glutamine analogs Grant US-10842763-B2 United States of America 24 Nov 2020
Methods and compositions for treating metabolic reprogramming disorders Grant US-10568868-B2 United States of America 25 Feb 2020